Results 251 to 260 of about 126,024 (329)

TACE combined with sorafenib induces complete remission in an elderly patient with hepatocellular carcinoma, hepatic venous tumor thrombus, and diffuse lung metastasis: a case study and literature review. [PDF]

Front Oncol
Guangsheng Z, Song L, Shunhang Y, Zhongyi D, Shunxiong T, Jun Z, Yuewei Z.   +6 more
europepmc   +1 more source

β-Sitosterol enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma via the FXR/LXR/ SREBP1/ FASN pathway. [PDF]

Transl Oncol
Yan A, Huang Z, Kong L, Cheng Z, Song Y, Li X, Jiang P, Yan Y.   +7 more
europepmc   +1 more source

Lysophosphatidic acid-induced Arf6-driven macropinocytosis of CD147⁺ extracellular vesicles promotes sorafenib resistance of hepatocellular carcinoma. [PDF]

Int J Biol Sci
Qian L, Fu Z, Chen P, Guo Y, Li Y, Wang Y, Wang B, Zhang Q, Guo Q, Wu L, Kucharzewska P, Chen Z, Piao Y, Zhang S.   +13 more
europepmc   +1 more source

Synergistic Strategies in Systemic Therapy for Advanced Hepatocellular Carcinoma. [PDF]

Glob Chall
Yu Y, Jiang Y, Yang Y, Glandorff C, Fang W, Sun M.   +5 more
europepmc   +1 more source

The RNA demethylases ALKBH5 and FTO regulate translation of the ATF4 mRNA in sorafenib-treated hepatocarcinoma cells [PDF]

Pauline Adjibade, Rachid Mazrouï
openalex   +1 more source

A cost-effectiveness analysis of a new and more effective treatment for unresectable hepatocellular carcinoma-from a Chinese perspective. [PDF]

Ann Med
Chen J, Dong Z, Shou B, Huang Z, Huang L, Sun G.   +5 more
europepmc   +1 more source

Synergistic antitumor activity of sorafenib and the NUPR1 inhibitor LZX-2-73 in multiple cancer models. [PDF]

Cell Death Dis
Liu X, Estaras M, Cosialls E, Peng L, Santofimia-Castaño P, Iovanna J.   +5 more
europepmc   +1 more source

Impact of clinical characteristics and genetic profiles on outcomes of allogeneic stem cell transplantation with sorafenib maintenance in FLT3-ITD AML patients: A multi-center, retrospective study

Yeqian Zhao, Chuanhe Jiang, Y. Luo, Guifang Ouyang, Lieguang Chen, Jian Yu, Yamin Tan, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Yishan Ye, Luxin Yang, Congxiao Zhang, Jimin Shi, He Huang, Xiaoxia Hu, Yanmin Zhao   +16 more
openalex   +1 more source

RETRACTED: El-Masry et al. Potential Antitumor Activity of Combined Lycopene and Sorafenib Against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. <i>Pharmaceuticals</i> 2024, <i>17</i>, 527. [PDF]

Pharmaceuticals (Basel)
El-Masry TA, El-Nagar MMF, El Mahdy NA, Alherz FA, Taher R, Osman EY.   +5 more
europepmc   +1 more source

Research advances in sorafenib combined with orthotopic liver transplantation, radiofrequency ablation, and transarterial chemoembolization in treatment of hepatocellular carcinoma

, 2014
Zhang Mingjua
openalex   +2 more sources